ORIGINAL RESEARCH
Published on 19 Jul 2021
Berberine Reduces Aβ42 Deposition and Tau Hyperphosphorylation via Ameliorating Endoplasmic Reticulum Stress
doi 10.3389/fphar.2021.640758
- 3,921 views
- 48 citations
- Frontiers in Neuroscience
- Neuropharmacology
- Research Topics
- Drug Repurposing in Neurodegenerative and Neuropsychiatric Disorders
Drug Repurposing in Neurodegenerative and Neuropsychiatric Disorders
41k
Total downloads
184k
Total views and downloads
Articles
MINI REVIEW
Published on 28 Jun 2021
Role of Plant-Derived Natural Compounds in Experimental Autoimmune Encephalomyelitis: A Review of the Treatment Potential and Development Strategy
doi 10.3389/fphar.2021.639651
- 4,195 views
- 13 citations
ORIGINAL RESEARCH
Published on 31 May 2021
Methylprednisolone Induces Neuro-Protective Effects via the Inhibition of A1 Astrocyte Activation in Traumatic Spinal Cord Injury Mouse Models
doi 10.3389/fnins.2021.628917
- 6,437 views
- 33 citations
REVIEW
Published on 26 May 2021
Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?
doi 10.3389/fnins.2021.656475
- 8,606 views
- 18 citations
REVIEW
Published on 24 May 2021
Repurposing of Anti-Diabetic Agents as a New Opportunity to Alleviate Cognitive Impairment in Neurodegenerative and Neuropsychiatric Disorders
doi 10.3389/fphar.2021.667874
- 5,971 views
- 37 citations
REVIEW
Published on 30 Apr 2021
Repurposing Ketamine in Depression and Related Disorders: Can This Enigmatic Drug Achieve Success?
doi 10.3389/fnins.2021.657714
- 29,190 views
- 19 citations
ORIGINAL RESEARCH
Published on 22 Apr 2021
Emulated Clinical Trials from Longitudinal Real-World Data Efficiently Identify Candidates for Neurological Disease Modification: Examples from Parkinson’s Disease
doi 10.3389/fphar.2021.631584
- 7,484 views
- 13 citations
ORIGINAL RESEARCH
Published on 15 Apr 2021
Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease
doi 10.3389/fphar.2021.613211
- 3,665 views
- 13 citations
REVIEW
Published on 29 Mar 2021
Repurposing Immunomodulatory Imide Drugs (IMiDs) in Neuropsychiatric and Neurodegenerative Disorders
doi 10.3389/fnins.2021.656921
- 9,674 views
- 24 citations
REVIEW
Published on 23 Mar 2021
Drug Repurposing in the Treatment of Traumatic Brain Injury
doi 10.3389/fnins.2021.635483
- 11,626 views
- 21 citations
REVIEW
Published on 19 Mar 2021
Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
doi 10.3389/fnins.2021.653377
- 10,274 views
- 26 citations
ORIGINAL RESEARCH
Published on 29 Dec 2020
Farnesyl Transferase Inhibitor Lonafarnib Enhances α7nAChR Expression Through Inhibiting DNA Methylation of CHRNA7 and Increases α7nAChR Membrane Trafficking
doi 10.3389/fphar.2020.589780
- 2,918 views
- 2 citations
Published in
Frontiers in Neuroscience
Neuropharmacology
Participating Journals
Frontiers in Neurology
Neuropharmacology
- 2.7 impact factor
- 4.9 citescore
Frontiers in Pharmacology
- 4.4 impact factor
- 7.8 citescore